Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Recruiting now

Conditions studied: Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty

In brief

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Key facts

Study ID

NCT01186133

Run by

Seung-Jung Park

People needed

50000

Starts

2009-01-01

Expected to finish

2030-12-01

Last updated by the study team

2026-06-30

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• coronary disease amenable to percutaneous coronary intervention (PCI)
• no clinical and lesion limitations

You may not qualify if…

• patients with a mixture of several DES
• terminal illness with life expectancy less than 1 year
• patients with cardiogenic shock

Where it is running

• Korean centres — Multiple Locations, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.